Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Leong

Showing results (171-180 of 186) with videos related to

Pageof 19
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2005
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancerKim A Margolin, James H Doroshow, Paul Frankel, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 14, 2019
Impact of mismatches in HbA<sub>1c</sub> vs glucose values on the diagnostic classification of diabetes and prediabetesA Gonzalez, Y Deng, A N Lane, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2000
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine AJ W Raschko, T W Synold, W Chow, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2009
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium StudyStephen I Shibata, James H Doroshow, Paul Frankel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumorsE M Newman, M Carroll, S A Akman, et al.
British Journal of Cancer|June 13, 2001
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcomeG Somlo, J H Doroshow, T Synold, et al.
Journal of Ovarian Research|July 17, 2023
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancerA W Adamson, Y C Ding, L Steele, et al.
American Journal of Clinical Oncology|October 11, 2008
Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium TrialY Yen, Dean W Lim, Vincent Chung, et al.
Research Square|March 3, 2023
Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian CancerA W Adamson, Y C Ding, L Steele, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2004
A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignanciesS I Shibata, R Pezner, D Chu, et al.
Pageof 19

Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2005
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancerKim A Margolin, James H Doroshow, Paul Frankel, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 14, 2019
Impact of mismatches in HbA<sub>1c</sub> vs glucose values on the diagnostic classification of diabetes and prediabetesA Gonzalez, Y Deng, A N Lane, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2000
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine AJ W Raschko, T W Synold, W Chow, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2009
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium StudyStephen I Shibata, James H Doroshow, Paul Frankel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumorsE M Newman, M Carroll, S A Akman, et al.
British Journal of Cancer|June 13, 2001
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcomeG Somlo, J H Doroshow, T Synold, et al.
Journal of Ovarian Research|July 17, 2023
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancerA W Adamson, Y C Ding, L Steele, et al.
American Journal of Clinical Oncology|October 11, 2008
Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium TrialY Yen, Dean W Lim, Vincent Chung, et al.
Research Square|March 3, 2023
Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian CancerA W Adamson, Y C Ding, L Steele, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2004
A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignanciesS I Shibata, R Pezner, D Chu, et al.
Pageof 19